Krebs Biochemicals and Industries Limited has issued a regulatory intimation to BSE Limited and National Stock Exchange of India Ltd regarding an upcoming board meeting.
The Board of Directors meeting is scheduled for Thursday, August 6, 2026. The primary agenda includes consideration and adoption of the unaudited financial results for the first quarter ended June 30, 2026.
The company had previously communicated on June 22, 2026 about the trading window closure for insiders as defined under SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window remains closed from the closure of business hours on June 30, 2026 until 48 hours after the declaration of the company's unaudited financial results for Q1 June 2026.